Hong Kong stocks rose 6% with Akeso Pharmaceuticals-B (06855.HK) surging; Neulak Polaris-1 study approved by the US FDA and European EMA.

According to the Wise Financial News app, Asiaray Medicine-B (06855.HK) surged over 6%, and as of the time of publication, it increased by 5.67% to 64.2 Hong Kong dollars, with a trading volume of 1993.31 million Hong Kong dollars.